Journal
JOURNAL OF IMMUNOLOGY
Volume 190, Issue 1, Pages 259-269Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1202177
Keywords
-
Categories
Funding
- Singapore Immunology Network
- Horizontal Programme on Infectious Diseases, Agency for Science, Technology and Research, Singapore
- European Union [261202]
- National University of Singapore
- Agency for Science, Technology and Research postgraduate scholarship
Ask authors/readers for more resources
Chikungunya virus (CHIKV) is an alphavirus that causes chronic and incapacitating arthralgia in humans. Injury to the joint is believed to occur because of viral and host immune-mediated effects. However, the exact involvement of the different immune mediators in CHIKV-induced pathogenesis is unknown. In this study, we assessed the roles of T cells in primary CHIKV infection, virus replication and dissemination, and virus persistence, as well as in the mediation of disease severity in adult RAG2(-/-), CD4(-/-), CD8(-/-), and wild-type CHIKV C57BL/6J mice and in wild-type mice depleted of CD4(+) or CD8(+) T cells after Ab treatment. CHIKV-specific T cells in the spleen and footpad were investigated using IFN-gamma ELISPOT. Interestingly, our results indicated that CHIKV-specific CD4(+), but not CD8(+), T cells are essential for the development of joint swelling without any effect on virus replication and dissemination. Infection in IFN-gamma(-/-) mice demonstrated that pathogenic CD4(+) T cells do not mediate inflammation via an IFN-gamma-mediated pathway. Taken together, these observations strongly indicate that mechanisms of joint pathology induced by CHIKV in mice resemble those in humans and differ from infections caused by other arthritogenic viruses, such as Ross River virus. The Journal of Immunology, 2013, 190: 259-269.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available